Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

Nubia Muñoz, Susanne K Kjaer, Kristján Sigurdsson, Ole-Erik Iversen, Mauricio Hernandez-Avila, Cosette M Wheeler, Gonzalo Perez, Darron R Brown, Laura A Koutsky, Eng Hseon Tay, Patricía J Garcia, Kevin A Ault, Suzanne M Garland, Sepp Leodolter, Sven-Eric Olsson, Grace W K Tang, Daron G Ferris, Jorma Paavonen, Marc Steben, F Xavier BoschJoakim Dillner, Warner K Huh, Elmar A Joura, Robert J Kurman, Slawomir Majewski, Evan R Myers, Luisa L Villa, Frank J Taddeo, Christine Roberts, Amha Tadesse, Janine T Bryan, Lisa C Lupinacci, Katherine E D Giacoletti, Heather L Sings, Margaret K James, Teresa M Hesley, Eliav Barr, Richard M Haupt

    489 Citationer (Scopus)

    Abstract

    The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).
    OriginalsprogEngelsk
    TidsskriftNational Cancer Institute. Journal (Print)
    Vol/bind102
    Udgave nummer5
    Sider (fra-til)325-39
    Antal sider15
    ISSN0027-8874
    DOI
    StatusUdgivet - 3 mar. 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women'. Sammen danner de et unikt fingeraftryk.

    Citationsformater